Allison Harley
Director, Pharmacovigilance Scientist
Meet the rest of our
see all team members
Barry Ticho, M.D., Ph.D.
Chief Medical Officer, Stoke Therapeutics
Bo Cumbo
President and Chief Executive Officer, Solid Biosciences
Kiran Musunuru, M.D., Ph.D.
Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania
Yasser (Yas) El-Gamal, J.D.
Senior Vice President, Legal Affairs and Chief Intellectual Property Counsel
Allison Dorval
Chief Financial Officer
Sheila Mikhail, J.D.
Co-Founder and Former Chief Executive Officer, AskBio; Co-Founder and Chief Executive Officer, Jurata Thin Film
Leslie Stolz, Ph.D.
Senior Vice President, Regulatory Affairs
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Michael MacLean
Chief Financial Officer and Chief Business Officer, Avidity Biosciences
Fred Fiedorek, M.D.
Chief Medical Officer
Jason Politi
Chief Technical Operations Officer
Nia Tatsis, Ph.D.
Executive Vice President and Chief Regulatory and Quality Officer, Vertex Pharmaceuticals
Andrew Geall, Ph.D.
Co-Founder and Chief Development Officer, Replicate Bioscience
Troy Lister, Ph.D.
Chief Scientific Officer
Issi Rozen
Venture Partner, GV
Lonnel Coats
Chief Executive Officer and Director, Lexicon Pharmaceuticals
Andrew Ashe, J.D.
President, Chief Operating Officer and General Counsel
J. Keith Joung, M.D., Ph.D.
Robert B. Colvin, M.D. Endowed Chair in Pathology and Pathologist, Massachusetts General Hospital; Professor of Pathology, Harvard Medical School
Krishna Yeshwant, M.D.
Managing Partner, GV
Anthony Philippakis, M.D., Ph.D.
Chief Data Officer, Broad Institute of MIT and Harvard
Burt Adelman, M.D.
Chairman of the Board; former EVP and Chief Medical Officer, Dyax
Jodie Morrison
Chief Executive Officer and Director, Q32 Bio Inc.
Joan Nickerson
Chief Administrative Officer
Eugene Braunwald, M.D.
Distinguished Hersey Professor of Medicine at Harvard Medical School
